White Brook Capital's Q3 2026 investor letter highlights Rapid Micro Biosystems (NASDAQ:RPID), a life sciences firm providing automated microbial detection and quality control for biopharmaceutical manufacturing. The stock closed at $0.82 on October 21, 2026, with a $40.94 million market cap, down 71.86% year to date and trading in a 52-week range of $0.76 to $4.94. White Brook says the business has strengthened, margin targets have been met, and the MilliporeSigma relationship is on track. However, the share price has suffered from an ill-conceived equity issuance and concerns that more could follow. The firm believes the share price implies a more pessimistic outlook for next year's cash use than is likely.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
RPIDfundraisingpharmaceuticalsbiotechnology
Open a keyword to see other news on the same topic.
Related news
- Stock Market Today: Dow Rises As Oil Prices Back Off; Biotech, Pharma Stocks Shine (Live Coverage)
- Cathie Wood Bought More CRISPR Therapeutics Stock 2 Days in a Row. Here's What She Sees in the Biotech Stock.
Ark Invest founder Cathie Wood holds $379.1 million of CRISPR Therapeutics shares and bought $1.1 million on Oct. 9 and $2.3 million on Oct. 12 through the ARK Genomic Revolution ETF, even though the stock is down more than 25% over the past year. CRISPR's only approved therapy, Casgevy, posted $76 million in Q2 revenue, up 151% year over year, but its $2.2 million list price and the 60% revenue share going to Vertex limit its economics. The company's net loss narrowed to $91.2 million from $208.5 million, and it holds $2.36 billion in cash. The article also points to CTX-310, which cut LDL cholesterol by 53% and triglycerides by 48% after 12 months in a phase 1a trial, and to a phase 2 readout for blood thinner CTX611 expected later this year.
- Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?
Ark Investment Management, led by Cathie Wood, holds $220.4 million in Beam Therapeutics (BEAM) shares through its Ark ETFs, and recently bought another $2.8 million worth on Oct. 12 and 13 for the Ark Genomic Revolution (ARKG) fund. Beam develops gene-editing therapies using base editing, which changes single nucleotides without cutting both DNA strands, and its lead candidate, risto-cel, is in early trials for severe sickle cell disease. The company is far from profitable: first-half revenue was $32.2 million, up 50.5%, and loss per share was $2.09 versus $2.12 a year earlier, while $1.15 billion in cash is expected to fund operations through mid-2029. The stock is down more than 14% this year, and the article notes that the next 12 to 18 months will bring dense data readouts that could significantly lift the shares if positive.
- CII extends the distribution period for convertible bonds
CII (HoSE) has extended by 30 days the period for distributing convertible bonds code CII426001, an offering of nearly 67.2 million bonds to existing shareholders at a rate of 10 rights per bond, and is seeking State Securities Commission approval. The 25-year bonds pay 0% interest for the first 12 interest periods and 14.5% a year after that, and CII expects to raise about VND 6,720 billion for investment in projects. Registration and payment for the remaining undistributed bonds runs from 22/10 to 3/11/2026. HFIC, the Ho Chi Minh City State Investment and Finance Company, had registered to sell 27.4 million rights, but no investors registered to buy, so it still holds 27.4 million rights, equal to 4.08% of CII's capital. CII will also set 5/11/2026 as the record date for an extraordinary general meeting approving its 2027-2032 infrastructure development orientation.
- Pigment Raises $250M at $2.3B Valuation
Pigment, an AI business planning and performance management platform, announced a $250 million Series E round at a $2.3 billion valuation. The round is led by the Scaleup Europe Fund managed by EQT, with participation from WIL (World Innovation Lab), existing investors Greenoaks, ICONIQ, IVP and Meritech, and a planned investment from NVIDIA. The company said its annual recurring revenue (ARR) surpassed $100 million earlier this year, again doubling year over year, and that 85% of new metrics on its platform are now created by an AI agent. The new capital will fund R&D and engineering expansion around its Graphite engine as it moves toward autonomous planning.
- OpenAI seeks to accelerate fundraising ahead of Anthropic planned IPO
Related markets
Latest news
- Apple's $1,999 iPhone Duo hits stores Friday amid limited supplies
Apple's first foldable smartphone, the iPhone Duo, goes on sale Friday at a starting price of $1,999, but supply is tight. Pre-orders sold out almost immediately and delivery times now stretch into late January, while Apple Stores have only limited units for walk-in customers. Scalpers are reselling the phone on sites like eBay for more than $4,000. The iPhone generated $209.58 billion of Apple's $416.16 billion revenue in 2025, well ahead of Services at $109.15 billion.
- Could California's billionaire tax hit Mark Zuckerberg?
Hosts Julie Hyman, Pras Subramanian and Jake Conley discuss California's proposed one-time 5% billionaire wealth tax and its possible impact on Meta CEO Mark Zuckerberg. They note the tax has not passed, but say the uncertainty appears to be weighing on Meta shares. Based on the company's filings, the panel describes how Zuckerberg raised the possibility of leaving California and how the board moved to address it, which they see as evidence the board is not disinterested. They also acknowledge the argument that Zuckerberg's central role in Meta's AI efforts makes his departure a stability risk, while pointing out that Sergey Brin has left California.
- Spotify Jumps 10% as Premium Subscriber Growth Tops Forecasts; Sirius XM Stays Put
Spotify shares rose about 10% to $579.49 after the company reported Q3 2026 Premium subscribers of 306 million, 1 million above its guidance, with 6 million net additions and growth in every region. Management guided to 316 million subscribers and €820 million in operating income for Q4, and credited audiobooks with lifting acquisition and retention. Revenue rose 16.3% to $5.58 billion, but GAAP diluted EPS of $2.79 missed the $2.85 consensus due to higher share-based compensation charges, and operating expenses grew 26%. Sirius XM was roughly flat at $26.85, down 0.4%, reflecting different business models: Spotify relies mainly on streaming subscriptions, while Sirius XM sells radio subscriptions largely through vehicles.
- American Airlines Sinks 4% as Fuel Costs Push Outlook to Full-Year Loss; Delta and United Airlines Drop 3%
American Airlines fell about 4% to $11.72 after reporting record Q3 2026 revenue of $16.34 billion and an adjusted loss of $0.28 per share, smaller than the $0.33 expected. Its outlook worsened, with a full-year adjusted loss now forecast at $1 to $1.60 per share, replacing July guidance that ranged from a $0.65 loss to a $0.65 profit. The Q4 plan assumes jet fuel at $4.70 a gallon, after Q3 jet fuel costs rose 67.5% to $4.63 billion as the average price climbed to $3.85 from $2.37. Premium revenue grew 22.9% and managed corporate sales 27.6%, but the airline carries $29.6 billion in debt and finance leases against a $4.2 billion stockholders' equity deficit. Delta and United Airlines, exposed to the same fuel market, fell about 3%.
- DeepSeek Completes Nearly $15 Billion Funding Round, Largest Ever in China
Chinese AI startup DeepSeek is finalizing a funding round of about 100 billion yuan (US$14.98 billion) from existing and new investors, including Tencent and CATL, according to Reuters citing sources. The round values the company at 500 billion yuan (about $74.9 billion) before the new capital, and its size is double the initial target of 50 billion yuan. Other participants include Midea, Meituan, Geely and GigaDevice, with more than 15 investors in total. The terms and investor list are not final and the deal is expected to close within days, while DeepSeek, CATL and Tencent have not commented. The move follows DeepSeek's hiring of CITIC Securities in September to prepare a potential IPO on China's STAR Market.
- Tesla and SpaceX Held On to All 30,221 Bitcoin in Q3. Is Elon Musk Still Bullish on BTC?
As of September 30, Tesla and SpaceX together held all 30,221 Bitcoin, worth about $2.53 billion, without buying or selling any coins in Q3 2026. Tesla holds 11,509 BTC ($962 million) and SpaceX holds 18,712 BTC (about $1.57 billion). Tesla reported net income of $787 million, down 42.7% from a year earlier, and a roughly $290 million Bitcoin mark-to-market gain on its books accounted for more than a third of that figure. Bitcoin later fell back to about $81,881, roughly 35% below its October 2025 all-time high of $126,080. The article says Tesla's unchanged holdings since 2022 point to inertia rather than renewed conviction, and neither company has announced plans to buy or sell.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.